» Articles » PMID: 24553908

The Global Burden of Hip and Knee Osteoarthritis: Estimates from the Global Burden of Disease 2010 Study

Abstract

Objective: To estimate the global burden of hip and knee osteoarthritis (OA) as part of the Global Burden of Disease 2010 study and to explore how the burden of hip and knee OA compares with other conditions.

Methods: Systematic reviews were conducted to source age-specific and sex-specific epidemiological data for hip and knee OA prevalence, incidence and mortality risk. The prevalence and incidence of symptomatic, radiographic and self-reported hip or knee OA were included. Three levels of severity were defined to derive disability weights (DWs) and severity distribution (proportion with mild, moderate and severe OA). The prevalence by country and region was multiplied by the severity distribution and the appropriate disability weight to calculate years of life lived with disability (YLDs). As there are no deaths directly attributed to OA, YLDs equate disability-adjusted life years (DALYs).

Results: Globally, of the 291 conditions, hip and knee OA was ranked as the 11th highest contributor to global disability and 38th highest in DALYs. The global age-standardised prevalence of knee OA was 3.8% (95% uncertainty interval (UI) 3.6% to 4.1%) and hip OA was 0.85% (95% UI 0.74% to 1.02%), with no discernible change from 1990 to 2010. Prevalence was higher in females than males. YLDs for hip and knee OA increased from 10.5 million in 1990 (0.42% of total DALYs) to 17.1 million in 2010 (0.69% of total DALYs).

Conclusions: Hip and knee OA is one of the leading causes of global disability. Methodological issues within this study make it highly likely that the real burden of OA has been underestimated. With the aging and increasing obesity of the world's population, health professions need to prepare for a large increase in the demand for health services to treat hip and knee OA.

Citing Articles

Comparison of hyaluronic acid and platelet-rich plasma in knee osteoarthritis: a systematic review.

Xu H, Shi W, Liu H, Chai S, Xu J, Tu Q BMC Musculoskelet Disord. 2025; 26(1):236.

PMID: 40069655 PMC: 11895219. DOI: 10.1186/s12891-025-08474-6.


Effects of intra-articular applied rat BMSCs expressing alpha-calcitonin gene-related peptide or substance P on osteoarthritis pathogenesis in a murine surgical osteoarthritis model.

Stockl S, Taheri S, Maier V, Asid A, Toelge M, Clausen-Schaumann H Stem Cell Res Ther. 2025; 16(1):117.

PMID: 40045368 PMC: 11884178. DOI: 10.1186/s13287-025-04155-2.


Factors influencing UK arthroplasty surgeons' decision-making between total and medial unicompartmental knee surgery: A vignette-based behavioural experiment.

Nurek M, Musbahi O, Baldacchino M, Hamm R, Hing C, Cobb J J Exp Orthop. 2025; 12(1):e70178.

PMID: 40028417 PMC: 11869565. DOI: 10.1002/jeo2.70178.


Health literacy status and its relationship with physical therapy and rehabilitation applications in patients with knee osteoarthritis.

Altan L, Akif Cila M Turk J Phys Med Rehabil. 2025; 70(4):452-459.

PMID: 40028413 PMC: 11868868. DOI: 10.5606/tftrd.2024.13546.


Instant gait classification for hip osteoarthritis patients: a non-wearable sensor approach utilizing Pearson correlation, SMAPE, and GMM.

Choi W, Jeong H, Oh S, Jung T Biomed Eng Lett. 2025; 15(2):301-310.

PMID: 40026883 PMC: 11871253. DOI: 10.1007/s13534-024-00448-2.